Is amoxicillin useless now because of resistance?
Community maps, not a funeral for 500 mg
Hospital ICU gram-negatives and a child's strep throat do not share a resistance bar. Treating them as one 'amoxicillin is finished' story is how people demand a fluoroquinolone for a virus.
Community antibiograms - outpatient urine, ear, and sinus isolates plus throat-culture programmes - are the maps this file uses. They update by region and by year. A 2014 slide from another county is not your 2026 desk.
Amoxil 500 mg remains a first-line chip where the organism is still susceptible and the diagnosis is bacterial. It is a wasted chip where the syndrome is viral or the local bar for that site is already red.
Dr. Amara Okoro stamps stewardship as organism-plus-site, not brand loyalty. She does not culture your throat from this page.
Farm-feed tetracycline headlines belong in an agricultural column. They do not rewrite a group A strep susceptibility table.
County health departments still publish outpatient bars when they have the isolates. If your county does not, use the nearest hospital outpatient sheet and say so on the card. A national blog average is a last resort.
Clavulanate as the next line when the map turns
Amoxicillin-clavulanate is the community step when beta-lactamase producers are likely or when a recent amoxicillin course already failed a bacterial syndrome. Diarrhea rises. That is the trade, not a reason to jump to a last-line oral fluoroquinolone for sinusitis.
Dose the amoxicillin component for the pneumococcus, not the clavulanate component for folklore. Extra clavulanate does not make a resistant pneumococcus susceptible. It only makes the gut louder.
H. pylori regimens that still include amoxicillin depend on combination chemistry and local clarithromycin maps - a different survey. Do not use a 500 mg solo course as 'ulcer treatment.'
Change nothing from a study page. Bring the syndrome, the last antibiotic, and any culture to your own clinician - the ledger disclaimer is the stop line.
H. pylori combination weeks that still include amoxicillin are a separate survey with clarithromycin maps. A solo 500 mg week is not ulcer treatment and should not be counted as an H. pylori 'failure.'
Stewardship surveys count syndromes, not slogans
CDC outpatient audits still find amoxicillin - and azithromycin - written for viral bronchitis and undifferentiated colds. Those prescriptions do not 'cover resistance.' They write the next year's bars.
Allergy labels that say 'penicillin' without a reaction history retire 500 mg for people who could take it. Delabeling clinics exist because that false red bar pushes cephalosporins and fluoroquinolones the isolate did not need.
Dental prophylaxis rules narrowed. A 500 mg pulse before every cleaning is not modern endocarditis prevention for most patients. Ask whether the indication still exists before counting a 'resistance' failure that was never an infection.
This file does not replace a local antibiogram. If your hospital publishes one, that sheet beats a national blog post and it beats this page.
Azithromycin written for a cold trains pneumococcus too. Retiring Amoxil 500 while keeping the macrolide 'because it is five days' is not stewardship. It is a shorter slogan.
Dental 500 mg pulses after the prophylaxis rules narrowed still show up in leftover drawers. Those leftovers then become unofficial UTI courses. That path is how a throat-green chip becomes a urine-red story.
Beta-lactamase bugs a lone 500 mg cannot cover
Haemophilus influenzae and Moraxella catarrhalis make beta-lactamase in a large minority of community respiratory isolates. Plain amoxicillin 500 mg does not outrun that enzyme. Clavulanate exists for those bars.
Sinus protocols that start with 500 mg assume a likely pneumococcus or a watchful-wait miss. They fail on purpose when the local Haemophilus beta-lactamase rate is high and symptoms are severe. That is not 'amoxicillin resistance' as a slogan. It is the wrong chip for the enzyme.
Pasteurella from a dog bite is still usually amoxicillin-susceptible; many bite protocols still prefer a beta-lactamase inhibitor because of mixed mouth flora. Site again beats brand.
Enterococcus in urine is a different enzyme story. Do not borrow a sinus bar to treat a catheter culture.
Moraxella almost always carries the enzyme in community series. If the desk thinks Moraxella is likely, plain 500 mg is the wrong chip before the culture even returns.
Urine E. coli versus the same capsule at the throat
Community E. coli urine isolates often show amoxicillin resistance in the 30 to 50 percent band, sometimes higher. A 500 mg capsule that cured strep last winter is a coin-flip for uncomplicated cystitis this week unless your local antibiogram says otherwise.
Nitrofurantoin, trimethoprim-sulfamethoxazole where still susceptible, and other first-line UTI chips exist because this bar turned red years ago. Empiric Amoxil 500 for dysuria is how people collect a second drug after 48 hours of fever.
A urine culture before treating in men, in pregnancy, and in recurrences is how the map stays honest. A leftover 500 mg blister from a dental visit is not a UTI protocol.
Compare the hospital gram-negative heat on the Cipro 750 resistance map if you want a different site and a different overused chip. Do not merge those bars into one panic.
Pregnancy cystitis is a culture-first column. Empiric 500 mg from a dental leftover is not obstetric protocol. The map and the fetus both want a named isolate.
Asymptomatic bacteriuria outside pregnancy is usually a no-treat bar. Chasing a dirty dip with Amoxil 500 writes resistance without treating a syndrome.
Throat strep still sits in the susceptible column
Group A Streptococcus remains almost uniformly susceptible to penicillin and amoxicillin in US surveillance. That is why 500 mg three times daily - or the twice-daily high-dose variants some paediatric desks use - still sits first for proven strep pharyngitis.
Failure after a documented strep course is more often re-exposure, non-adherence, or a viral co-infection than a newly resistant strep. Declaring Amoxil 'broken' because a sore throat lasted five days skips the culture.
Centor scores and rapid antigen tests exist so viral colds do not eat 500 mg capsules. Green sputum is not a susceptibility result. Colour is a myth that fills resistance maps with unnecessary exposures.
Scarlet fever and rheumatic-fever prevention still lean on timely beta-lactam treatment. That public-health column is why we have not retired the chip for strep even while other bars turned red.
Household siblings share cups and rewrite a 'cure' as a new acquisition. Treating one child and leaving the symptomatic sibling untested is how 500 mg looks like failure at day seven.
Otitis high-dose cards when pneumococcus hardens
Streptococcus pneumoniae is the organism that forced the high-dose amoxicillin card in acute otitis media. Intermediate and resistant pneumococci need higher middle-ear concentrations. AAP guidance pushed 80-90 mg/kg/day in children in high-resistance communities - not because 500 mg is 'stronger branding.'
Adult 500 mg three times daily is not that paediatric high-dose card. Copying a child's mg/kg math onto an adult sinus prescription without looking at local pneumococcal bars is cargo-cult stewardship.
Watchful waiting for mild otitis in selected older children is also on the map. Treating every red ear with 500 mg trains the next year's pneumococcus. The survey question is not 'did we have a capsule' - it is 'did this ear need one.'
If the child was on amoxicillin last month and the ear returns, many desks step to amoxicillin-clavulanate because beta-lactamase producers and resistant pneumococci are now more likely. That is a map move, not a loyalty change.
Adult sinus 500 mg three times is not paediatric math. Copying an 80 mg/kg ear card onto a 70 kg sinus complaint without looking at local pneumococcal bars is how people invent 'high-dose' folklore.
Delayed prescription letters - fill only if the ear is worse at 48 hours - cut unnecessary 500 mg starts in selected older children. That is also a resistance-map tool. It is not neglect.
Match the isolate before you retire Amoxil
THL-S11 keeps Amoxil 500 on the desk where community maps still print susceptible: proven strep, selected otitis and sinus cases, and a few bite and dental lines. It retires the same capsule for most empiric cystitis and for viral coughs.
Resistance is a site-and-organism bar, not a brand funeral. Clavulanate is the next community line when the enzyme is the problem. Fluoroquinolones are not the consolation prize for a cold.
Read this year's outpatient antibiogram. Then let the person who examined you write the chip.
Keep the 500 mg capsule on the desk. Retire the habit of writing it for viruses and for urine without a map. Those are different sentences.
Bring last year's culture if you have one. A prior susceptible E. coli does not freeze the bar, but a prior resistant isolate should stop a leftover 500 mg experiment before it starts.
Viral cough plus coloured sputum still does not open 500 mg. If the exam changes - focal chest findings, high-risk host - that is a new diagnosis, not a colour rule.
Local bars move year to year. A 2022 slide that retired Amoxil for sinus may not match this winter's pneumococcal sheet. Date the map you cite.
Talk with your own clinician or pharmacist before you change a tablet or a dose. Open the ledger disclaimer.
Last Updated
Reader mail
Reader questions on this article
Answered by Dr. Amara Okoro, MD · Infectious disease & antimicrobial stewardship
Readers want a yes-or-no on whether Amoxil 500 still works. These answers sort the community bars by site.
No. Group A strep in US throat surveys is still almost uniformly susceptible, which is why 500 mg remains first-line for proven pharyngitis. Community urine E. coli is often 30 to 50 percent resistant, which is why empiric cystitis usually starts elsewhere. Pneumococcus sits in between and forced high-dose otitis cards in some regions. A headline that 'amoxicillin is dead' collapses those bars into one slogan. Ask which site and which organism. Then read this year's local antibiogram.
My strep test was positive. Why not start a 'stronger' antibiotic?
Because stronger is not a susceptibility result. For group A strep, amoxicillin or penicillin is already the right spectrum. Jumping to a macrolide or a fluoroquinolone adds side effects and trains other organisms without helping the strep. If you vomit the first doses or you have a true immediate penicillin allergy, that is a different chip - not a prestige upgrade. Finish the course you were given. Failure after a documented strep course is more often re-exposure than a new resistant strep.
The paediatrician used a huge mg/kg dose for my child's ear. Did they ignore the 500 mg label?
They were probably following the high-dose otitis card for pneumococcus, not ignoring Amoxil. Intermediate and resistant pneumococci need higher middle-ear levels. AAP math in high-resistance communities sits near 80-90 mg/kg/day. Adult 500 mg three times daily is not that card. Do not copy a child's mg/kg onto your own sinus prescription. If the ear fails after a recent amoxicillin course, many desks step to clavulanate because the map has shifted.
Can I use leftover 500 mg capsules for burning urine?
Usually a bad map move. Community E. coli often resists amoxicillin. A leftover dental blister is a coin-flip that can delay a drug the isolate actually likes. Men, pregnancy, fever, or flank pain need a clinician and usually a culture - not a drawer. If you already started leftovers, say so. Hidden doses scramble the next decision. This page cannot triage a UTI.
The antibiogram says Haemophilus makes beta-lactamase. Does 500 mg still cover my sinus?
Plain amoxicillin does not outrun that enzyme. If your clinician thinks Haemophilus is likely and your local beta-lactamase rate is high, clavulanate is the community step. Extra 500 mg chips will not fix an enzyme. They will only extend exposure. Mild sinus symptoms still often deserve watchful waiting plus saline, because even a 'correct' antibacterial is wasted on a virus.
I am labeled penicillin-allergic. Is Amoxil off the table forever?
Not if the label is a childhood rash that was never characterised. False penicillin labels retire 500 mg for people who could take it and push broader drugs the isolate did not need. Immediate anaphylaxis is a true stop. Delayed mild rash is often delabeling territory. An allergy clinic or a careful history does more for the resistance map than another azithromycin. Do not self-challenge. Bring the story.
Does a green or yellow sputum mean I need 500 mg?
No. Colour is not a culture. Viral bronchitis produces coloured sputum and still does not want amoxicillin. Stewardship surveys keep finding 500 mg written for colds, which is how next year's bars get worse. Fever, focal chest findings, or a high-risk host can change the diagnosis - that is an exam, not a tissue colour. If someone already gave you 500 mg for a cold, finishing a short leftover is not the same as starting a new unjustified course. Ask before you repeat it.
When is clavulanate the right next line instead of 'stronger' Cipro?
When the problem is a beta-lactamase producer in a community respiratory or bite mixed-flora setting, or when a recent amoxicillin course already failed a bacterial syndrome. Diarrhea is the trade. Fluoroquinolones are not the consolation prize for ordinary sinusitis - they have their own resistance and tendon ledger, filed separately on the Cipro 750 line. Dose the amoxicillin component for pneumococcus. Extra clavulanate does not rescue a resistant pneumococcus.
Our farm uses antibiotics in feed. Is that why my strep will not clear?
Agricultural antibiotic pressure is a real One Health column. It is not why group A strep stays susceptible, and it is not the usual reason a personal sore throat lingers. Human outpatient amoxicillin use, viral mis-prescribing, and household re-exposure sit closer to your throat. Do not merge a feedlot headline with a rapid strep result. If the test was negative, you may not have had strep. If it was positive and you missed doses, that is adherence, not a cow.
General education from a clinician, not personal medical advice. Bring your own history to your own prescriber.